Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

被引：0
|
作者：
Zachary D Horne
David A Clump
John A Vargo
Samir Shah
Sushil Beriwal
Steven A Burton
Annette E Quinn
Matthew J Schuchert
Rodney J Landreneau
Neil A Christie
James D Luketich
Dwight E Heron
机构：
[1] University of Pittsburgh Cancer Institute,Department of Radiation Oncology
[2] University of Pittsburgh Medical Center,Division of Thorcic and Foregut Surgery, Department of Cardiothoracic Surgery
来源：
Radiation Oncology | / 9卷
关键词：
Overall Survival; Planning Target Volume; Stereotactic Body Radiation Therapy; Gross Tumor Volume; SUVmax Cutoff;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of radiation dose to the immune system on disease progression and survival for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
    Wang, Xiaofeng
    Bai, Hui
    Gao, Miaomiao
    Guan, Yong
    Yu, Lu
    Li, Junyi
    Dong, Yang
    Song, Yongchun
    Tao, Zhen
    Meng, Maobin
    Wu, Zhiqiang
    Zhao, Lujun
    Yuan, Zhiyong
    RADIOTHERAPY AND ONCOLOGY, 2023, 186
  • [2] The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer
    Amin, Saber A.
    Alam, Morshed
    Baine, Michael J.
    Meza, Jane L.
    Bennion, Nathan R.
    Zhang, Chi
    Rahman, Ibur
    Lin, Chi
    RADIOTHERAPY AND ONCOLOGY, 2021, 155 : 254 - 260
  • [3] Stereotactic Body Radiation Therapy for Patients with Early-Stage Non-small Cell Lung Cancer Inoperable
    Pham, L. V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S518 - S518
  • [4] Stereotactic body radiation therapy for early-stage non-small-cell lung cancer
    Lo, Simon S.
    Fakiris, Achilles J.
    Papiez, Lech
    Abdulrahman, Ramzi
    McGarry, Ronald C.
    Henderson, Mark A.
    Forquer, Jeffrey A.
    Hoopes, David
    Timmerman, Robert D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (01) : 87 - 98
  • [5] Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
    Karen Huang
    Sharan Prasad
    Sung Jun Ma
    Han Yu
    Austin J. Iovoli
    Mark K. Farrugia
    Elizabeth U. Dexter
    Todd L. Demmy
    Nadia K. Malik
    Anurag K. Singh
    BMC Cancer, 23
  • [6] Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
    Aridgides, Paul
    Bogart, Jeffrey
    THORACIC SURGERY CLINICS, 2016, 26 (03) : 261 - +
  • [7] A PI3K gene expression signature predicts for recurrence in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy (SBRT)
    Sebastian, Nikhil T.
    Webb, Amy
    Shilo, Konstantin
    Robb, Ryan
    Xu-Welliver, Meng
    Haglund, Karl
    Brownstein, Jeremy
    DeNicola, Gina M.
    Shen, Changxian
    Williams, Terence M.
    CANCER, 2023, 129 (24) : 3971 - 3977
  • [8] Association of neutrophil-lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
    Huang, Karen
    Prasad, Sharan
    Ma, Sung Jun
    Yu, Han
    Iovoli, Austin J. J.
    Farrugia, Mark K. K.
    Dexter, Elizabeth U. U.
    Demmy, Todd L. L.
    Malik, Nadia K. K.
    Singh, Anurag K. K.
    BMC CANCER, 2023, 23 (01)
  • [9] Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer
    Haque, Waqar
    Verma, Vivek
    Polamraju, Praveen
    Farach, Andrew
    Butler, E. Brian
    Teh, Bin S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 264 - 269
  • [10] Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer
    Maquilan, Genevieve
    Timmerman, Robert
    CANCER JOURNAL, 2016, 22 (04): : 274 - 279
12345